FreeGuest Editorial Playing Russian roulette with two bullets at Zaporizhzhia nuclear plant July 21, 2023Vol.49 No.29By Robert Peter Gale
FreeIn the Archives Cancer History Project book spotlight: “Simone’s Maxims” July 21, 2023Vol.49 No.29
FreeTrials & Tribulations Engineering-level molecular diagnosis: A necessity for cancer treatment—and for a successful Moonshot July 21, 2023Vol.49 No.29By Michael P. Castro
SCOTUS decision on denying service to LGBTQ+ people opens doors for discrimination in cancer care July 14, 2023Vol.49 No.28By Alexandria Carolan
Using ctDNA as an endpoint in your cancer clinical trial? FDA wants to hear from you July 14, 2023Vol.49 No.28By Matthew Bin Han Ong
Capitol Hill House FY24 spending bill slashes NIH by 6%, NCI by 3% July 14, 2023Vol.49 No.28By Paul Goldberg
Guest Editorial Evaluation of COE requires a holistic approach; avoiding two fundamental fallacies July 14, 2023Vol.49 No.28By George J. Weiner
Guest Editorial The new breast cancer screening guidelines are not enough to save Black womenA breast surgical oncologist and breast radiologist weigh in July 14, 2023Vol.49 No.28By Vivian Jolley Bea and Kemi Babagbemi
Conversation with The Cancer Letter Once deemed a “functional wasteland,” Y chromosome is found to play a role in cancer immunityThe finding may alter biology textbooks July 07, 2023Vol.49 No.27By Jacquelyn Cobb
